Study on the Efficacy of Alprostadil Injection in Patients With Acute Ischemic Stroke

Not yet recruiting

Phase 4 Results N/A

Summary of Purpose

Ischemic stroke has a variety of treatments and currently drug therapy is one of the main treatments.A number of clinical studies have proved that alprostadil (PGE1) has pharmacological effects of significant dilation of blood vessels, inhibition of plate aggregation, anti-atherosclerosis and increased cerebral blood flow.Evaluate the 90-days efficacy by comparing two groups of patients'(one with...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 15 August 2017.

18 Aug 2017 8 Aug 2017 31 Dec 2018 30 Jun 2019 1 Aug 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

Not available

Contacts

Not available